Vascular Endothelial Growth Factor Genetic Variant is Associated with In-Stent Restenosis after Percutaneous Coronary Intervention
Background: In-stent restenosis (ISR) is an inevitable complication of percutaneous coronary intervention, with genetic factors thought to play a role in its pathogenesis. The VEGF gene can have an inhibitory effect on ISR development. Accordingly, in the present study, we investigated the role of...
Main Authors: | Saeedeh Asgarbeik, Aida Vahidi, Mandana Hasanzad, Mojgan Asadi, Mahsa M.Amoli |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2022-07-01
|
Series: | Journal of Tehran University Heart Center |
Subjects: | |
Online Access: | https://jthc.tums.ac.ir/index.php/jthc/article/view/1541 |
Similar Items
-
Gene Delivery from Stents for Prevention of In Stent Restenosis
by: Ilia Fishbein, et al.
Published: (2016-12-01) -
Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon
by: Yasser Gaber Metwally, et al.
Published: (2024-12-01) -
Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
by: Aslı Tanındı, et al.
Published: (2015-07-01) -
Hypersensitivity and in-stent restenosis in coronary stent materials
by: Wansong Hu, et al.
Published: (2022-09-01) -
Bioresorbable vascular scaffold for coronary in-stent restenosis: A novel concept
by: Surender Deora, et al.
Published: (2014-07-01)